Traditional Chinese medicinal composition for treating qi-blood deficiency induced aplastic anemia
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technique for aplastic and blood-deficiency, which is applied in drug combinations, blood diseases, medical formulas, etc., can solve the problems of high treatment costs, high prices, and unsatisfactory treatment effects, and achieve unique curative effects
Inactive Publication Date: 2017-04-26
钱建荣
View PDF4 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0004] Drugs for the treatment of aplastic anemia are expensive, costly and unsatisfactory
Modern medicine generally uses blood transfusion therapy combined with western medicine to treat aplastic anemia of Qi and blood deficiency type, but the adverse reactions are serious and it is difficult to use it for a long time
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0055] A traditional Chinese medicine composition for treating aplastic anemia of both qi and blood deficiency type, which is made from the following raw materials: 10 parts of ginseng, 20 parts of saber bark fungus, 20 parts of ganoderma lucidum, 12 parts of astragalus, 12 parts of donkey-hide gelatin, 15 parts of Atractylodes macrocephala, 12 parts of Rehmannia glutinosa, 12 parts of angelica, 12 parts of white peony root, 15 parts of Milletanus spatula, 10 parts of Hedyotis diffusa, 6 parts of Limonium bicolor, 8 parts of Polygonum multiflorum, 8 parts of dried placenta powder, 6 parts of tangerine peel, 6 parts of roasted licorice.
Embodiment 2
[0057] A traditional Chinese medicine composition for treating aplastic anemia of Qi and blood deficiency type, which is made of the following raw materials: 25 parts of ginseng, 30 parts of saber bark fungus, 35 parts of ganoderma lucidum, 22 parts of astragalus, 22 parts of donkey-hide gelatin, 20 parts of Atractylodes macrocephala, 22 parts of rehmannia glutinosa, 25 parts of angelica, 22 parts of white peony root, 22 parts of Caulis Spatholobus, 20 parts of Hedyotis diffusa, 18 parts of Limonium bicolor, 15 parts of Polygonum multiflorum, 16 parts of dried placenta powder, 15 parts of tangerine peel, 15 parts of roasted licorice.
Embodiment 3
[0059] A traditional Chinese medicine composition for treating aplastic anemia of both qi and blood deficiency type, which is made from the following raw materials: 22 parts of ginseng, 22 parts of saber bark fungus, 22 parts of ganoderma lucidum, 18 parts of astragalus, 18 parts of donkey-hide gelatin, 18 parts of Atractylodes macrocephala, 15 parts of Rehmannia glutinosa, 16 parts of angelica, 16 parts of white peony root, 16 parts of Miltonia, 12 parts of Hedyotis diffusa, 12 parts of Limonium bicolor, 9 parts of Polygonum multiflorum, 9 parts of dried placenta powder, 9 parts of tangerine peel, 9 parts of roasted licorice.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention provides a traditional Chinese medicinal composition for treating qi-blood deficiency induced aplastic anemia. The traditional Chinese medicinal composition for treating qi-blood deficiency induced aplastic anemia is prepared from 10-25 parts of ginseng, 20-30 parts of fruiting body of Phellinus torulosus(Pers.)Bourd.et Galz., 20-35 parts of Mythic Fungus, 12-22 parts of Radix Astragali, 12-22 parts of donkey-hide gelatin, 15-20 parts of Rhizoma Atractylodis Macrocephalae, 12-22 parts of prepared rehmannia root, 12-25 parts of Chinese angelica root, 12-22 parts of white peony root, 15-22 parts of Caulis Spatholobi, 10-20 parts of Hedyotis diffusa, 6-18 parts of Limonium bicolor (Bag.) Kuntze, 8-15 parts of Polygonum multiflorum, 8-16 parts of placentin (electuary), 6-15 parts of dried orange peel and 6-15 parts of honey-fried licorice root. The purpose of the invention is to provide the traditional Chinese medicinal composition for treating qi-blood deficiency induced aplastic anemia, with the advantages of good treatment effect, high effective rate and no toxic or side effects on human bodies.
Description
technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for treating aplastic anemia of Qi and blood deficiency type. Background technique [0002] Aplastic anemia (AA, aplastic anemia) is a bone marrow hematopoietic failure, mainly manifested as low bone marrow hematopoietic function, pancytopenia, anemia, bleeding, and infection syndrome. The main clinical manifestations are anemia, bleeding and infection. Aplastic anemia belongs to the categories of "consumption" and "blood disease" in traditional Chinese medicine. Mainly manifested as symptoms of anemia, bleeding and infection, fever is relatively mild. [0003] Western medicine has not fully elucidated its etiology, and its treatment is relatively difficult. The traditional treatment requires regular blood transfusion, infusion and hospitalization. Also, currently using [0004] The medicines used in the treatment of apla...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more